Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMan Regulatory News (EMG)

Share Price Information for Man (EMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 262.60
Bid: 262.00
Ask: 262.60
Change: 2.60 (1.00%)
Spread: 0.60 (0.229%)
Open: 255.00
High: 262.80
Low: 255.00
Prev. Close: 260.00
EMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re share buy-back programme

19 Oct 2018 07:00

RNS Number : 5406E
Man Group plc
19 October 2018
 

Share buy-back programme

 

In April 2018, the Board announced a share repurchase programme for up to $100 million to return surplus capital to shareholders. This programme was completed on 15 October 2018.

As described in Man Group plc's (the "Company") announcement on 12 October 2018 Markel Corporation have entered into a definitive agreement to acquire the Company's 18.5% management fee interest in Nephila Holdings Limited. The acquisition, which remains subject to regulatory approvals, is currently expected to complete in the fourth quarter of 2018 and would generate net proceeds of around $130 million and would add an equivalent amount to the group's regulatory capital surplus.

The Company's policy is to distribute available capital surpluses to shareholders over time, by way of higher dividend payments and/or share repurchases, while maintaining a prudent balance sheet, after taking into account required capital (including liabilities for future earn-out payments) and potential strategic opportunities.

In line with this policy the Company today announces its intention to repurchase up to $100 million of shares. The repurchase will be implemented pursuant to an irrevocable buy-back programme that the Company expects to launch in the coming days.

 

Enquiries

Fiona Smart

Head of Investor Relations

+44 20 7144 2030

fiona.smart@man.com

 

 

This announcement contains inside information.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRMPBMTMBBBTIP
Date   Source Headline
1st Oct 20216:03 pmRNSTransaction in Own Shares
1st Oct 20217:00 amRNSTotal Voting Rights
30th Sep 20215:52 pmRNSTransaction in Own Shares
29th Sep 20216:05 pmRNSTransaction in Own Shares
28th Sep 20216:07 pmRNSTransaction in Own Shares
27th Sep 20215:50 pmRNSTransaction in Own Shares
24th Sep 20216:06 pmRNSTransaction in Own Shares
23rd Sep 20215:49 pmRNSTransaction in Own Shares
22nd Sep 202110:13 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
22nd Sep 202110:06 amGNWMan Group PLC : Form 8.3 - John Laing Group plc
21st Sep 20215:47 pmRNSTransaction in Own Shares
21st Sep 20219:19 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
20th Sep 20215:41 pmRNSTransaction in Own Shares
17th Sep 20215:54 pmRNSTransaction in Own Shares
17th Sep 20213:00 pmRNSDirectorate Change
16th Sep 20215:52 pmRNSTransaction in Own Shares
15th Sep 20216:16 pmRNSTransaction in Own Shares
15th Sep 202111:14 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
14th Sep 20215:52 pmRNSTransaction in Own Shares
14th Sep 20211:56 pmRNSMan Group PLC : Form 8.3 - Strongbridge biopharma plc
13th Sep 20215:51 pmRNSTransaction in Own Shares
13th Sep 202112:15 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
13th Sep 202112:06 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
10th Sep 20215:55 pmRNSTransaction in Own Shares
10th Sep 20217:21 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
9th Sep 20215:58 pmRNSTransaction in Own Shares
9th Sep 202111:40 amRNSDirector/PDMR Shareholding
9th Sep 20216:56 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
8th Sep 20215:53 pmRNSTransaction in Own Shares
8th Sep 20214:25 pmRNSDirector/PDMR Shareholding
8th Sep 20217:15 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
7th Sep 20215:54 pmRNSTransaction in Own Shares
3rd Sep 20215:47 pmRNSTransaction in Own Shares
3rd Sep 20217:58 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
3rd Sep 20217:02 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
2nd Sep 20215:56 pmRNSTransaction in Own Shares
2nd Sep 20216:59 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
2nd Sep 20216:48 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
1st Sep 20215:54 pmRNSTransaction in Own Shares
1st Sep 20217:21 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
1st Sep 20217:06 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
1st Sep 20217:00 amRNSTotal Voting Rights
31st Aug 20216:02 pmRNSTransaction in Own Shares
31st Aug 20217:47 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
31st Aug 20217:22 amGNWMan Group PLC : Form 8.3 - Stonebridge Biopharma plc
30th Aug 20217:22 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
27th Aug 20215:41 pmRNSTransaction in Own Shares
27th Aug 20218:20 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
26th Aug 20215:35 pmRNSTransaction in Own Shares
26th Aug 202110:18 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.